Skip to main content

stock

AUPH · Aurinia Pharmaceuticals Inc.

What Aurinia Pharmaceuticals Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live AUPH price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on AUPH.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
133,051,168 as of 2026-08-05 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
48.4%
Net
100.8%

Returns

ROE
51.1%
ROA
39.6%

Health

Current ratio
5.4x
Debt/equity
—

Deep value

NCAV
$363.93M
NCAV per share
$2.74
Price/NCAV
Locked
NNWC
$24.91M
NNWC per share
$0.19
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$83.22M—Gross profit: unreported by this company.$46.34M$37.41M
10-Q filed 2026-08-06
2026-03-31$77.70M—Gross profit: unreported by this company.$41.42M$34.35M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$77.11M—Gross profit: unreported by this company.$33.24M$210.79M
10-K filed 2026-02-26
2025-09-30$73.47M—Gross profit: unreported by this company.$29.75M$31.55M
10-K filed 2026-02-26
2025-06-30$70.01M—Gross profit: unreported by this company.$20.08M$21.51M
10-Q filed 2026-08-06
2025-03-31$62.47M—Gross profit: unreported by this company.$21.85M$23.34M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$59.87M—Gross profit: unreported by this company.-$1.67M$1.43M
10-K filed 2026-02-26
2024-09-30$67.77M—Gross profit: unreported by this company.$11.75M$14.35M
10-K filed 2026-02-26
Assets
$792.26M
Equity
$614.86M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$283.06M$104.91M$287.20M—
2024-12-31$235.13M-$4.69M$5.80M—
2023-12-31$175.51M-$91.69M-$78.00M—
2022-12-31$134.03M-$111.47M-$108.20M—
2021-12-31$45.60M-$180.74M-$181.00M—
2020-12-31$50.12M-$104.29M-$102.68M—
2019-12-31$318,000-$90.94M-$88.39M—
2018-12-31$463,000-$55.24M-$53.08M—

Company filings

events

  • Other event

    Other event
    Aug 198-K
  • Results

    Results
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 48-K
  • Acquisition or sale completed

    Acquisition or sale completed
    May 118-K
  • Results

    Results
    May 78-K
  • Material agreement, Regulation FD disclosure

    Material agreementRegulation FD disclosure
    Apr 38-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Robertson Stephen P.

    Chief Legal Officer

    Sale$190,427

    Sep 11, 4:26 PM ET

  • Robertson Stephen P.

    Chief Legal Officer

    Sale$355,946

    Aug 25, 9:29 PM ET

All insider trades for AUPH

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named AUPH, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about AUPH.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about AUPH.

nakagai

Signals on AUPH come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the AUPH board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Aurinia Pharmaceuticals Inc. (AUPH): SEC filings, financials and insider trades · Nakagai